Showing results (261-270 of 447) with videos related to
Sort By:
Pageof 45
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2017
Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung CancerReinhard Büttner, John R Gosney, Birgit Guldhammer Skov, et al.Cancers|July 24, 2019
Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung CancerDennis Wang, Nhu-An Pham, Timothy M Freeman, et al.Lung Cancer (Amsterdam, Netherlands)|May 15, 2025
Prognostic and predictive effects of TP53 co-mutation in patients with non-small cell lung cancer with rare treatable driver mutationsJamie Feng, Katrina Hueniken, Zhen Jason Fan, et al.Clinical and Translational Radiation Oncology|June 14, 2019
Computer-assisted image analysis of the tumor microenvironment on an oral tongue squamous cell carcinoma tissue microarraySangjune Laurence Lee, Michael Cabanero, Martin Hyrcza, et al.Lung Cancer (Amsterdam, Netherlands)|May 12, 2009
Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experienceRavi J Menezes, Heidi C Roberts, Narinder S Paul, et al.Plos Biology|November 24, 2016
SOX2 and PI3K Cooperate to Induce and Stabilize a Squamous-Committed Stem Cell Injury State during Lung Squamous Cell Carcinoma PathogenesisBo Ram Kim, Emily Van de Laar, Michael Cabanero, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Phase II study of preoperative gefitinib in clinical stage I non-small-cell lung cancerHumberto Lara-Guerra, Thomas K Waddell, Maria A Salvarrey, et al.Lung Cancer (Amsterdam, Netherlands)|April 1, 2014
A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC)Abul Kalam Azad, Xin Qiu, Kevin Boyd, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 24, 2016
Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural MesotheliomaHarvey I Pass, Chandra Goparaju, Osvaldo Espin-Garcia, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10Charles A Butts, Keyue Ding, Lesley Seymour, et al.Pageof 45